What are Jeuveau rebates compared to Botox for medspas?

Jeuveau rebates range from $3–5 per unit at mid-tier volumes, compared to Botox's $1.50–3 range. Jeuveau's Evolus Rewards program offers higher rebates at lower volume thresholds, making it more accessible for independent medspas with moderate injection volumes.

Should I switch from Botox to Jeuveau for my medspa?

Switching entirely is risky because Jeuveau has fewer patient requests by name due to its smaller installed base and shorter clinical track record (FDA approval 2019). Jeuveau works best as a secondary toxin or for price-sensitive patient segments while you maintain Botox for patients requesting it specifically.

How does Evolus Rewards compare to AbbVie's Alle program?

Evolus Rewards offers simplified loyalty tiers and higher per-unit rebates at lower volume thresholds than Botox's tiered Alle model. This gives independent medspas more negotiating leverage and easier qualification for rebate tiers.

What should I analyze before switching toxins at my medspa?

Model per-unit economics and patient acquisition cost for each toxin. Compare the rebate structure against your typical monthly volumes, patient demand by brand, and whether switching costs (staff retraining, inventory) justify the rebate savings.

Why is Jeuveau targeting medspas instead of dermatology practices?

Jeuveau has positioned itself as the medspa-friendly alternative to Botox by offering aggressive per-unit rebates and simplified loyalty programs designed for independent practices. This direct-to-medspa channel strategy bypasses Botox's entrenched relationships with larger dermatology groups.

Monday, August 24, 2026 Never miss a recall or a rule change Go Pro · $20/mo →

RegulatoryAbbVie Launches Phase 2 Forehead Lines Studytoday MarketFacial Rejuvenation Market Forecast to Hit $5.66B by 20302 days ago Business & M&AAllergan Aesthetics Overhauls Loyalty Programtoday Devices & TechXERF Technology Enters Australian Market for Skin Tightening2 days ago Business & M&AEvolus Expands Estyme to Canada, Australia, New Zealandtoday MarketArm Fat Now Top Body Sculpting Concern in Singapore2 days ago Devices & TechSofwave Hits One Million Treatments Milestonetoday RegulatoryCKD Bio Pursues China Botox Approval—2027 Launch Targeted2 days ago RegulatoryRevance Wins FDA Nod for Under-Eye Injectablesyesterday MarketGLP-1 Pill Era Is Forcing Beauty Market Shiftyesterday InjectablesAEON Releases Expanded ABP-450 Botox Biosimilar Datayesterday Devices & TechUltherapy PRIME Real-Time Imaging Reshapes Midface Liftingyesterday

Injectables

Evolus Expands Jeuveau Rewards Program — Aggressive Pricing War Targets Medspa Market Share

Evolus's enhanced loyalty program and aggressive rebate positioning challenge AbbVie's Botox dominance in the medspa channel.

By Evan at Inside MedSpa · Jul 17, 2026

1-YEAR MOVE

EOLS ▼15.6% ABBV ▲11.6%

1-year price move by ticker
Ticker	Company	1-year change
EOLS	Evolus	−15.6%
ABBV	AbbVie (Allergan Aesthetics)	+11.6%

Evolus has filed a material SEC event (8-K) related to Jeuveau (prabotulinumtoxinA) and its Evolus Rewards loyalty program, signaling expanded marketing and rebate initiatives targeting independent medspas. Jeuveau has positioned itself as the medspa-friendly alternative to Botox, leveraging aggressive per-unit rebates and simplified loyalty tiers to capture share from AbbVie's entrenched Alle program.

Inside MedSpa Pro

You've reached your free articles this week.

Keep reading every article, unlock the full trackers, and get the twice-a-week intelligence brief — from $20/mo, or $200/yr (two months free). Never miss a recall or a rule change.

Every article, unlocked — no weekly limit
The full 50-state law tracker, stock & M&A watch
The twice-a-week, 2-minute intelligence brief
Recalls, FDA clearances & safety signals as they hit

See everything you get →

Cancel anytime, one click · 14-day money-back on annual

https://insidemedspa.com/article/evolus-jeuveau-newtox-rewards-program-expansion/

Discussion

Free alerts

Get flagged before it costs you.

We'll flag the moment a recall or rule change hits your practice. One email a week, one click to leave.

Free · weekly · unsubscribe anytime. Privacy.

This morning's brief · 6 AM

The free version stops here.

What today's moves mean for your margins — and exactly what to do — already went out to Pro. By the time the trade press explains it, the window to act has closed.

Go Pro · $20/mo Two minutes a morning. Cancel anytime.

Live · Market movers

STRATA Skin Sciences-50%Hims & Hers Health+6.03%Estée Lauder+6.02%Bausch Health (Solta)-5.43%The Beauty Health Company (HydraFacial)+3.65%

The full stock & M&A watch →

FDA Activity — Aesthetic Devices

Monthly 510(k) clearances vs. recalls.

510(k) clearances Recalls

FDA Activity — Aesthetic Devices — Monthly 510(k) clearances vs. recalls.
Month	510(k) clearances	Recalls
Jun '25	0	4
Jul '25	0	1
Sep '25	0	1
Oct '25	0	2
Jan '26	0	1
Feb '26	0	5
Mar '26	0	5
Apr '26	0	19
May '26	7	18
Jun '26	34	8
Jul '26	23	4
Aug '26	5	0

The 50-state regulation tracker →

Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.

The twice-a-week intelligence brief Go Pro · $20/mo →

Evolus Expands Jeuveau Rewards Program — Aggressive Pricing War Targets Medspa Market Share

Share

Discussion

Leave a comment

By the time it's news, it's too late.